Home Other Building Blocks 313229-90-2
313229-90-2
Catalog No.:AA00J0QN

313229-90-2 | CB-TE2A

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
N/A
in stock  
$377.00   $264.00
- +
500mg
N/A
in stock  
$1,068.00   $748.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00J0QN
Chemical Name:
CB-TE2A
CAS Number:
313229-90-2
Molecular Formula:
C16H30N4O4
Molecular Weight:
342.4338
SMILES:
C1CN2CCN(CCCN(CC2)CC(=O)O)CCN(C1)CC(=O)O
Properties
Computed Properties
 
Complexity:
383  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
-4.7  

Literature

Title: Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.

Journal: Bioconjugate chemistry 20120718

Title: Molecular imaging of very late antigen-4 (α4β1 integrin) in the premetastatic niche.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120501

Title: Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20111201

Title: Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110801

Title: PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20110701

Title: Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.

Journal: PloS one 20110101

Title: In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Journal: Cancer biotherapy & radiopharmaceuticals 20101201

Title: (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.

Journal: Nuclear medicine and biology 20090401

Title: Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.

Journal: Molecular imaging 20090101

Title: Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20081101

Title: In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20070801

Title: Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20070201

Title: Investigation of copper-azamacrocyclic complexes by high-performance liquid chromatography.

Journal: Biomedical chromatography : BMC 20060101

Title: Optimization of labeling and metabolite analysis of copper-64-labeled azamacrocyclic chelators by radio-LC-MS.

Journal: Nuclear medicine and biology 20050101

Title: Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20041215

Title: Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

Journal: Journal of medicinal chemistry 20040311

Title: Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.

Journal: Journal of medicinal chemistry 20020117

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:313229-90-2 Molecular Formula|313229-90-2 MDL|313229-90-2 SMILES|313229-90-2 CB-TE2A